LV10391B - Use of derivatives of alkylphosphoric acid for healing of psoriasis - Google Patents

Use of derivatives of alkylphosphoric acid for healing of psoriasis Download PDF

Info

Publication number
LV10391B
LV10391B LVP-92-169A LV920169A LV10391B LV 10391 B LV10391 B LV 10391B LV 920169 A LV920169 A LV 920169A LV 10391 B LV10391 B LV 10391B
Authority
LV
Latvia
Prior art keywords
alkylamino
alkyl
der
oder
halogen
Prior art date
Application number
LVP-92-169A
Other languages
English (en)
Latvian (lv)
Other versions
LV10391A (lv
Inventor
Eibl Hansj Rg
Unger Clemens
Engel J Rgen
Original Assignee
Asta Medica Ag
Max Planck Ges Zur Firderung D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV10391(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Medica Ag, Max Planck Ges Zur Firderung D filed Critical Asta Medica Ag
Publication of LV10391A publication Critical patent/LV10391A/xx
Publication of LV10391B publication Critical patent/LV10391B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-92-169A 1989-09-27 1992-10-27 Use of derivatives of alkylphosphoric acid for healing of psoriasis LV10391B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (2)

Publication Number Publication Date
LV10391A LV10391A (lv) 1995-02-20
LV10391B true LV10391B (en) 1995-10-20

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-169A LV10391B (en) 1989-09-27 1992-10-27 Use of derivatives of alkylphosphoric acid for healing of psoriasis

Country Status (17)

Country Link
EP (2) EP0916343A1 (no)
JP (1) JP3176615B2 (no)
CA (1) CA2026278C (no)
DD (1) DD298052A5 (no)
DE (1) DE4029747C2 (no)
EG (1) EG19338A (no)
FI (1) FI904726A0 (no)
HU (1) HU209589B (no)
IE (1) IE903464A1 (no)
LT (1) LT3804B (no)
LV (1) LV10391B (no)
MC (1) MC2150A1 (no)
NO (1) NO904184L (no)
PT (1) PT95422B (no)
RU (1) RU1837877C (no)
UA (1) UA19335A (no)
ZA (1) ZA907702B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4233044A1 (de) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
JP2002501015A (ja) 1998-01-22 2002-01-15 アスタ メディカ アクチエンゲゼルシャフト リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品
DE102006004821B4 (de) * 2006-01-30 2020-12-10 Cuma Kilic Sammelbehältnis für Abfall und Bauschutt
WO2011003430A1 (en) * 2009-07-09 2011-01-13 Expergen Drug Development Gmbh Liquid pharmaceutical form of alkylphosphocholine and method of preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
CA1338627C (en) * 1985-12-04 1996-10-01 Hansjorg Eibl Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
DE3829899C2 (de) * 1988-09-02 1994-12-15 Reutter Werner Glyceringlycophosphatide und diese enthaltende pharmazeutische Mittel zur Bekämpfung von Hauterkrankungen

Also Published As

Publication number Publication date
MC2150A1 (fr) 1992-03-10
EP0916343A1 (de) 1999-05-19
JPH03130228A (ja) 1991-06-04
DE4029747A1 (de) 1991-04-11
JP3176615B2 (ja) 2001-06-18
EG19338A (en) 1994-12-30
HU209589B (en) 1994-08-29
DE4029747C2 (de) 2003-10-02
LTIP1488A (en) 1995-06-26
LT3804B (en) 1996-03-25
EP0419998A3 (en) 1991-10-23
LV10391A (lv) 1995-02-20
RU1837877C (ru) 1993-08-30
CA2026278A1 (en) 1991-03-28
HUT55992A (en) 1991-07-29
ZA907702B (en) 1991-07-31
DD298052A5 (de) 1992-02-06
HU906233D0 (en) 1991-03-28
CA2026278C (en) 1996-04-30
NO904184L (no) 1991-04-02
UA19335A (uk) 1997-12-25
NO904184D0 (no) 1990-09-26
FI904726A0 (fi) 1990-09-26
PT95422B (pt) 1997-07-31
PT95422A (pt) 1991-05-22
EP0419998A2 (de) 1991-04-03
IE903464A1 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
CA1223212A (en) Hair-growing agent
DE60008360T2 (de) Topisch antiandrogen für haarausfall und andere hyperandrogene zustände
DE69912790T2 (de) Farnesyl protein transferase inhibitoren zur behandlung von arthropathien
DE3507024C2 (de) Lösung zur Augenbehandlung
EP0708640B1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
EP0011237A1 (de) Polyäther-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3305755A1 (de) N-phenyl-benzamid-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkranungen des immunsystems
DE3443231A1 (de) Polysubstituierte naphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung auf dem pharmazeutischen und kosmetischen gebiet
DE3005580C2 (no)
DE2241742C3 (de) Verwendung von Hydroxyprolinderivaten bei der äußerlichen Behandlung von Bindegewebserkrankungen
DE2749492A1 (de) Antithrombosemittel
DE69816493T2 (de) Extrakt aus entzündetem Gewebe als Inhibitor der Stickstoffmonoxid-Produktion
LV10391B (en) Use of derivatives of alkylphosphoric acid for healing of psoriasis
DE69911755T2 (de) Synthetische endogene cannabinoidanaloge und ihre verwendungen
DE69727239T2 (de) Bis zu 1% enthaltendes flavonoid extrakt von gingko biloba mit ceramiden für die orale hygiene und diese enthaltende zusammensetzungen
DE1767163C3 (de) Blutdrucksenkendes Arzneimittel
EP0420798B1 (de) Antimikrobielle Zusammensetzungen
LU83138A1 (de) Topische pharmazeutische praeparate,enthaltend salze von alkancarbonsaeuren sowie neue carbonsaeuresalze und verfahren zu ihrer herstellung
DE3248837T1 (de) Zusammensetzungen fuer die behandlung von glaukom
EP0009777A1 (de) Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE60005525T2 (de) 2-aminotetraline zur behandlung von glaukom
EP0009793A2 (de) Pharmazeutisches Mittel, enthaltend 2-(Retinyliden)-malonsäurederivat, Verfahren zu seiner Herstellung und Verwendung
DE2140765C3 (de) Neue 2-(4'-Chlorbenzyl)-phenole, Verfahren zu ihrer Herstellung und bakteriostatisches Mittel
DE1900772B2 (de) Salz aus N JS-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE1918907C3 (de) Antiseborrhoeisches Mittel